| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |